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Gastrointestinal stromal tumor (GIST) is the most com-mon mesenchymal neoplasm with malignant potentialthat arises from the c-KIT (CD117)-positive intestinalcells of Cajal in the gastrointestinal tract.1 GIST ac-
counts for 0.1% to 3.0% of all tumors in the gastrointestinal tract
and occurs in 60% of tumors in the stomach, 35% of tumors in the
small bowel, and less than 1% of tumors in the esophagus.1
Metastases of GIST commonly develop in the abdominal cavity
and liver, and rarely in the lymph nodes (LNs).1,2 The standard
treatment of GIST is a complete surgical resection without a
regional lymphadenectomy.3 We describe a rare case of LN me-
tastases from an esophageal GIST.
Clinical Summary
A 52-year-old man was hospitalized with a 1-month history of
chest pain and dysphagia. His medical and family history were
unremarkable. He had a 30-year history of smoking 25 cigarettes
per day and occasionally drank alcohol. An esophagogastroscopy
showed an ulcerated large mass partially covered with normal
mucosa, which was located on the left wall of the esophagus 34 cm
from the incisors. Another lesion with an ulcerated elevation,
which was almost completely covered with normal mucosa, was
found at the gastric fundus. A barium swallow showed a well-
outlined tumor of 8  4 cm on the left esophageal wall of the
lower third of the thoracic esophagus and an elevated lesion with
an ulcer at the gastric fundus (Figure 1, A). A computed tomo-
graphic scan revealed thickening of the wall extending from the
distal esophagus to the gastric fundus and a well-outlined tumor in
the left lateral esophageal wall involving the lumen of the gastric
fundus (Figure 1, B). An apparent lymphadenopathy was observed
around the distal esophagus and gastric fundus (Figure 1, B). Dis-
tant metastases, such as in the liver and lung, were not observed.
The tumor was preoperatively diagnosed to be an esophageal,
poorly differentiated squamous cell carcinoma with regional LN
metastases according to the clinical and histopathologic findings.
A subtotal esophagectomy reconstructed with a gastric tube
through the retrosternal route was performed to completely resect
the tumor with dissection of cervical, mediastinal, and abdominal
LNs. The patient had an uneventful postoperative recovery.
The tumor was a well-circumscribed, gray-white fibrous mass
measuring 9.5 cm, involving the entire layer of the esophagus
(Figure 2, A). A histopathologic examination showed the interlac-
ing bundles or whorls of spindle-shaped cells with elongated
blunt-ended nuclei (Figure 2, A). The mitotic index was 15/50 in
high-power fields. LN metastases around the gastric fundus were
histologically confirmed (Figure 2, B). Immunohistochemical stud-
ies showed the tumor cells to stain diffusely for c-KIT and CD34,
and not for S-100 or -smooth muscle actin.
This tumor was diagnosed to be esophageal GIST with high-
grade malignancy based on the International Consensus on GIST
criteria.3
The patient is asymptomatic without any evidence of recur-
rence 18 months after surgery with the adjuvant administration of
imatinib (Gleevec, Novartis, Basel, Switzerland), which is a signal-
transduction inhibitor of c-KIT, for 12 months as a clinical trial.
Discussion
Most GISTs exhibit activating mutations of c-KIT and serve as a
model for molecular-based diagnosis and treatment.1 The preop-
erative diagnosis of GIST is difficult in any region mainly because
of the low frequency and difficulty of the biopsy.
In this case, the ulcerated tumor was located in the distal
esophagus and had regional LN metastases. The clinical findings
of most cases suggest the presence of an epithelial malignant
tumor and led to the false preoperative diagnosis of an undiffer-
entiated esophageal cancer that was morphologically similar to
GIST. To our knowledge, this is the first case report of overt LN
metastases from an esophageal GIST.
Miettinen and colleagues4 reported that 48 of 68 esophageal
mesenchymal tumors (71%) were leiomyomas and 17 (25%) were
GISTs, and that 12 of 17 esophageal GISTs (71%) were classified
as high-grade malignancies. This study indicates that GISTs are
rare among esophageal mesenchymal tumors, although many of
them are classified as high-grade malignancies. The present case is
asymptomatic without recurrence at 18 months after surgery de-
spite the high-grade malignancy with LN metastases. This may be
due to the complete surgical resection with extensive dissection of
LNs and the adjuvant administration of imatinib.2,5
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This seems to be a rare case of esophageal GIST with LN
metastases. Diagnosis of an esophageal tumor should thus in-
clude the possibility of GIST, notwithstanding the presence of
LN metastases. Immunohistochemistry with c-KIT is a key tool
for this diagnosis. Analyses of the clinical, histopathologic, and
molecular– biologic characteristics of GIST with LN metastases
would help in selecting the optimal treatments for GIST, while
shedding light on the mechanism of the malignant progression
of GIST.
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Figure 1. A, Barium swallow showed a well-outlined tumor at the
left esophageal wall of the lower third of the thoracic esophagus
and an elevated lesion with an ulcer at the gastric fundus.
B, Computed tomographic scan revealed thickening of the esoph-
ageal wall and lymphadenopathy around the distal esophagus
and gastric fundus.
Figure 2. A, The resected tumor was a well-circumscribed, gray–
white fibrous mass. The tumor was composed of interlacing
bundles or whorls of spindle-shaped cells with elongated blunt-
ended nuclei. Mitotic figures were recognized (hematoxylin-
eosin). B, LN metastases around the gastric fundus were histo-
logically confirmed (hematoxylin-eosin).
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